Lipid Microsphere Formulation Containing Rifampicin Targets Alveolar Macrophages

REFERENCES

• Deol P., Khuller G. K., Joshi K. Therapeutic efficacies of isoniazid and rifampin encapsulated in lung-specific stealth liposomes against Mycobacterium tuberculosis infection induced in mice. Antimicrob. Agents Chemother. 1997a; 41: 1211–1214
   PubMed Web of Science ®Google Scholar
• Deol P., Khuller G. K. Lung specific stealth liposomes: stability, biodistribution and toxicity of liposomal antitubercular drugs in mice. Biochim. Biophys. Acta 1997b; 1334: 162–172
   Google Scholar
• Drobniewski F., Nikolayevsky V., Asmolov A., Bazhora Y., Servetsky S. Increasing trends in HIV and TB rates in Odessa and the Ukraine. Int. J. Std. AIDS 2005; 16: 374–378
   PubMed Web of Science ®Google Scholar
• Dutt M., Khuller G. K. Chemotherapy of Mycobacterium tuberculosis infections in mice with a combination of isoniazid and rifampicin entrapped in poly (DL-lactide-co-glycolide) microparticles. J. Antimicrob. Chemother. 2001; 47: 829–835
   PubMed Web of Science ®Google Scholar
• Edwards D. A., Hanes J., Caponetti G, Hrkach J, Ben-Jebria A, Eskew M. L., Mintzes J., Deaver D., Lotan N., Langer R. Large porous particles for pulmonary drug delivery. Science 1997; 276: 1868–1871
   PubMed Web of Science ®Google Scholar
• Hoshi K., Mizushima Y., Kiyokawa S., Yanagawa A. Prostaglandin E1 incorporated in lipid microspheres in the treatment of peripheral vascular diseases and diabetic neuropathy. Drugs Exptl. Clin. Res. 1986; 12: 681–685
   PubMedGoogle Scholar
• Igarashi R., Takenaga M., Matsuda T. Distribution of a lipid microsphere preparation. Adv. Drug Del. Rev. 1996; 20: 147–154
   Web of Science ®Google Scholar
• Ikegami M., Na C.-L., Korfhagen T. R., Whitsett J. A. Surfactant protein Dinfluences surfactant ultrastructure and uptake by alveolar type II cells. Am. J. Physiol. Lung Cell Mol. Physiol. 2005; 288: L552–L561
   PubMed Web of Science ®Google Scholar
• Justesen U. S., Andersen A. B., Klitgaard N. A., Brosen K., Gerstoft J., Pedersen C. Pharmacokinetic interaction between rifampin and the combination of indinavir and low-dose ritonavir in HIV-infected patients. Clin. Infect. Dis. 2004; 38: 426–429
   PubMed Web of Science ®Google Scholar
• Justo O. R., Moraes A. M. Incorporation of antibiotics in liposomes designed for tuberculosis therapy by inhalation. Drug Del. 2003; 10: 201–207
   PubMed Web of Science ®Google Scholar
• Kiyokawa S., Igarashi R., Iwayama T., Haramoto S., Matsuda T., Hoshi K., Mizushima Y. 99 mTc-labeled lipid microspheres (LM) would be useful for an imaging study of those diseases. Jpn. J. Inflam. 1987; 7: 551–557
   Google Scholar
• Makino K., Nakajima T., Shikamura M., Ito F., Ando S., Kochi C., Inagawa H., Soma G., Terada H. Efficient intracellular delivery of rifampicin to alveolar macrophages using rifampicin-loaded PLGA microspheres: effects of molecular weight and composition of PLGA on release of rifampicin. Colloids Surf. Biointerf. 2004; 36: 35–42
   PubMed Web of Science ®Google Scholar
• Mizushima Y., Hoshi K., Aihara H., Kurachi M. Inhibition of bronchoconstriction by aerosol of a lipid emulsion containing prostaglandin E1. J. Pharm. Pharmacol. 1983; 35: 397
   PubMed Web of Science ®Google Scholar
• Mizushima Y., Hamano T., Haramoto S., Kiyokawa A., Yanagawa A., Nakura K., Shintomi M., Watanabe M. Distribution of lipid microspheres incorporating prostaglandin E1 to vascular lesions. Prostagl. Leukotr. Essent. Fatty Acids 1990; 41: 269–272
   PubMed Web of Science ®Google Scholar
• Niemi M., Backman J. T., Fromm M. F., Neuvonen P. J., Kivisto K. T. Pharmacokinetic interactions with rifampicin : clinical relevance. Clin. Pharmacokinet 2003; 42: 819–850
   PubMed Web of Science ®Google Scholar
• O'Hara P., Hickey A. J. Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: manufacture and characterization. Pharmaceut. Res. 2000; 17: 955–956
   PubMed Web of Science ®Google Scholar
• Pandey R., Sharma A., Zahoor A., Sharma S., Khuller G. K., Prasad B. Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis. J. Antimicrob. Chemother. 2003; 52: 981–986
   PubMed Web of Science ®Google Scholar
• Pandey R., Khuller G. K. Subcutaneous nanoparticle-based antitubercular chemotherapy in an experimental model. J. Antimicrob. Chemother. 2004; 54: 266–268
   PubMed Web of Science ®Google Scholar
• Pillai R. S., Yeates D. B., Miller I. F., Hickey A. J. Controlled dissolution from wax-coated aerosol particles in canine lungs. J. Appl. Physiol. 1998; 84: 717–725
   PubMed Web of Science ®Google Scholar
• Russell D. G. Mycobacterium tuberculosis: here today, and here tomorrow. Nat. Rev. Mol. Cell Biol. 2001; 2: 569–577
   PubMed Web of Science ®Google Scholar
• Salem I. I., Flasher D. L., Duzgunes N. Liposome-encapsulated antibiotics. Meth. Enzymol. 2005; 391: 261–291
   PubMed Web of Science ®Google Scholar
• Sharma A., Pandey R., Sharma S., Khuller G. K. Chemotherapeutic efficacy of poly (DL-lactide-co-glycolide) nanoparticle encapsulated antitubercular drugs at sub-therapeutic dose against experimental tuberculosis. Int. J. Antimicrob. Agents 2004; 24: 599–604
   PubMed Web of Science ®Google Scholar
• Shoji Y., Mizushima Y., Yanagawa A., Yonaha T. Electron microscopic studies on tissue distribution of lipid microspheres used as drug delivery carriers. Drugs Exptl. Clin. Res. 1985; 11: 601–609
   PubMedGoogle Scholar
• Suarez S., O'Hara P., Kazantseva M., Newcomer C. E., Hopfer R., McMurray D. N., Hickey A. J. Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: screening in an infectious disease model. Pharm Res. 2001a; 18: 1315–1319
   PubMed Web of Science ®Google Scholar
• Suarez S., O'Hara P., Kazantseva M., Newcomer C. E., Hopfer R., McMurray D. N., Hickey A. J. Airways delivery of rifampin. J. Antimicrob. Chemother. 2001b; 48: 431–434
   PubMed Web of Science ®Google Scholar
• Tasdug S. A., Peerzada K., Koul S., Bhat R., Johri R. K. Biochemical manifestations of anti-tuberculosis drugs induced hepatotoxicity and the effect of silymarin. Hepatol. Res. 2005; 31: 132–135
   PubMed Web of Science ®Google Scholar
• Takenaga M., Igarashi R., Tsuji H., Mizushima Y. Enhanced antitumor activity and reduced toxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea administration in lipid microspheres to tumor-bearing mice. Jpn. J. Cancer Res. 1993a; 84: 1078–1085
   PubMedGoogle Scholar
• Takenaga M., Nakagawa T., Igarashi R., Mizushima Y. Application of lipid microspheres to prepare a thromboxane A2 receptor antagonist aerosol inhalation. J. Drug Targ. 1993b; 1: 293–301
   PubMed Web of Science ®Google Scholar
• Takenaga M. Application of lipid microspheres for the treatment of cancer. Adv. Drug Del. Rev. 1996; 20: 209–219
   Web of Science ®Google Scholar
• Takenaga M., Igarashi R., Matsumoto K., Takeuchi J., Mizushima N., Nakayama T., Morizawa Y., Mizushima Y. Lipid microsphere preparation of a lipophilic ceramide derivative suppresses colony formation in a murine experimental pulmonary metastasis model. J. Drug Targ. 1999; 7: 187–195
   PubMed Web of Science ®Google Scholar
• Takenaga M., Igarashi R., Mizushima Y. Possibility of Lipo Y-24180 as an injectable drug and an inhaler for the treatment of bronchoconstriction. J. Allerg. Int. 2000; 14: 143–149
   Google Scholar
• Ul-Ain Q., Sharma S., Khuller G. K. Chemotherapeutic potential of orally administered poly(lactide-co-glycolide) microparticles containing isoniazid, rifampin, and pyrazinamide against experimental tuberculosis. Antimicrob. Agents Chemother. 2003; 47: 3005–3007
   PubMed Web of Science ®Google Scholar
• Yoshida A., Matsumoto M., Hashizume H., Oba Y., Tomishige T., Inagawa H., Kohchi C., Hino M., Ito F., Tomoda K., Nakajima T., Makino K., Terada H., Hori H., Soma G. Selective delivery of rifampicin incorporated into poly(dl-lactic-co-glycolic) acid microspheres after phagocytotic uptake by alveolar macrophages, and the killing effect against intracellular Mycobacterium bovis Calmette-Guerin. Microbes. Infect. 2006; 8: 2484–2491
   PubMed Web of Science ®Google Scholar